| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ForGrowth III PA B.V. | 10% | 0% | $81,492,203 | +$25,772,203 | 10,237,714 | +46% | ForGrowth III PA B.V. | 18 Dec 2025 |
| RA CAPITAL MANAGEMENT, L.P. | 14% | +41% | $43,075,707 | +$24,407,302 | 5,411,521 | +131% | RA Capital Management, L.P. | 18 Dec 2025 |
| Verve Capital Ltd | 9.9% | 0% | $58,273,612 | +$47,958,533 | 4,297,464 | +465% | Verve Capital Limited | 31 Dec 2025 |
| FMR LLC | 6.5% | -42% | $37,185,222 | +$25,579,283 | 2,526,170 | +220% | FMR LLC | 31 Dec 2025 |
| Frazier Life Sciences Public Fund, L.P. | 5.8% | $17,973,688 | 2,258,001 | Frazier Life Sciences Public Fund, L.P. | 18 Dec 2025 | |||
| Venrock Healthcare Capital Partners III, L.P. | 9.9% | 0% | $30,049,977 | +$19,734,899 | 2,216,075 | +191% | Venrock Healthcare Capital Partners III, L.P. | 31 Dec 2025 |
| Paradigm Biocapital Advisors LP | 4.5% | -46% | $23,730,000 | 1,750,000 | 0% | Paradigm BioCapital Advisors LP | 31 Dec 2025 | |
| GREAT POINT PARTNERS LLC | 3.3% | -39% | $18,578,651 | +$1,839,021 | 1,370,107 | +11% | Great Point Partners, LLC | 31 Dec 2025 |
| Reprogrammed Interchange LLC | 18% | $48,045,191 | 1,204,442 | Reprogrammed Interchange LLC | 15 Oct 2025 | |||
| Qiming Venture Partners VIII-HC, L.P. | 2.8% | -53% | $14,777,241 | +$8,047,792 | 1,089,767 | +120% | Qiming Venture Partners VIII-HC, L.P. | 31 Dec 2025 |
As of 31 Dec 2025, 53 institutional investors reported holding 25,530,116 shares of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR). This represents 59% of the company’s total 43,408,727 outstanding shares.
The largest institutional shareholders of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 12% | 5,404,998 | +173% | 0.73% | $70,697,374 |
| FCPM III SERVICES B.V. | 8.3% | 3,617,354 | +853% | 6.2% | $47,314,990 |
| Frazier Life Sciences Management, L.P. | 5.9% | 2,543,939 | 0.89% | $33,274,722 | |
| FMR LLC | 5.8% | 2,526,170 | +968% | 0% | $33,042,304 |
| VR ADVISER, LLC | 4.5% | 1,943,766 | +289% | 1.3% | $25,424,459 |
| Paradigm Biocapital Advisors LP | 4% | 1,750,000 | 0.61% | $22,890,000 | |
| GREAT POINT PARTNERS LLC | 3.2% | 1,370,107 | 5.8% | $17,921,000 | |
| NEXTBio Capital Management LP | 2.3% | 999,967 | 0% | 7.7% | $13,079,568 |
| Caligan Partners LP | 2.1% | 925,067 | 0.91% | $9,962,972 | |
| VANGUARD GROUP INC | 1.8% | 770,250 | +632% | 0% | $10,074,870 |
| BlackRock, Inc. | 1.1% | 465,636 | +1248% | 0% | $6,090,520 |
| CITADEL ADVISORS LLC | 1% | 433,894 | +7531% | 0% | $5,675,334 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.95% | 410,417 | 1.1% | $5,368,254 | |
| Laurion Capital Management LP | 0.73% | 317,243 | 0.28% | $4,149,538 | |
| UBS Group AG | 0.67% | 292,118 | +285% | 0% | $3,820,904 |
| FINDELL CAPITAL MANAGEMENT LLC | 0.53% | 231,000 | 1% | $3,021,480 | |
| MILLENNIUM MANAGEMENT LLC | 0.52% | 224,534 | +807% | 0% | $2,936,905 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.43% | 185,808 | +578% | 0% | $2,431,650 |
| TUDOR INVESTMENT CORP ET AL | 0.39% | 167,673 | 0.01% | $2,193,163 | |
| AMERIPRISE FINANCIAL INC | 0.38% | 163,061 | 0% | $2,132,838 | |
| GOLDMAN SACHS GROUP INC | 0.34% | 145,640 | +823% | 0% | $1,904,971 |
| Logos Global Management LP | 0.23% | 100,000 | 0.09% | $1,308,000 | |
| JANE STREET GROUP, LLC | 0.21% | 91,810 | +448% | 0% | $1,200,875 |
| STATE STREET CORP | 0.21% | 91,053 | +906% | 0% | $1,190,973 |
| JOHNSON & JOHNSON | 0.12% | 53,732 | 0% | 0.13% | $702,815 |